The effect of chromium intake on oxidative stress parameters: A systematic review and meta-analysis.


Journal

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
ISSN: 1878-3252
Titre abrégé: J Trace Elem Med Biol
Pays: Germany
ID NLM: 9508274

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 02 03 2021
revised: 15 10 2021
accepted: 18 10 2021
pubmed: 29 10 2021
medline: 3 3 2022
entrez: 28 10 2021
Statut: ppublish

Résumé

Trivalent chromium is a trace element thought to have a beneficial effect on oxidative stress (OS) parameters and inflammation. This review aimed to investigate the dose-response of chromium and summarize the effects of chromium supplementation on OS parameters in the literature. MEDLINE, Scopus, Web of Science and Cochrane CENTRAL databases were searched for RCTs published from inception to January 2021 evaluating the effect of chromium supplementation on OS parameters, namely MDA, TBARS, SOD, TAS, CAT, GPx, and GSH. A random-effects model was used to pool data and calculated standard mean difference and 95 % confidence intervals. Quantified heterogeneity among studies was assessed through Cochrane's I Nine studies enrolling 550 participants met the inclusion criteria. The obtained results indicate that chromium supplementation significantly increases TAC (SMD: 0.46; 95 % CI: 0.08, 0.84; I Chromium supplementation may improve OS parameters, however, due to high heterogeneity observed in the included studies, these findings should be interpreted with caution. Large RCTs on various patient groups evaluating the impact of chromium supplementation are needed to allow an adequate generalization of the benefits of chromium on human health.

Sections du résumé

BACKGROUND BACKGROUND
Trivalent chromium is a trace element thought to have a beneficial effect on oxidative stress (OS) parameters and inflammation. This review aimed to investigate the dose-response of chromium and summarize the effects of chromium supplementation on OS parameters in the literature.
METHODS METHODS
MEDLINE, Scopus, Web of Science and Cochrane CENTRAL databases were searched for RCTs published from inception to January 2021 evaluating the effect of chromium supplementation on OS parameters, namely MDA, TBARS, SOD, TAS, CAT, GPx, and GSH. A random-effects model was used to pool data and calculated standard mean difference and 95 % confidence intervals. Quantified heterogeneity among studies was assessed through Cochrane's I
RESULTS RESULTS
Nine studies enrolling 550 participants met the inclusion criteria. The obtained results indicate that chromium supplementation significantly increases TAC (SMD: 0.46; 95 % CI: 0.08, 0.84; I
CONCLUSION CONCLUSIONS
Chromium supplementation may improve OS parameters, however, due to high heterogeneity observed in the included studies, these findings should be interpreted with caution. Large RCTs on various patient groups evaluating the impact of chromium supplementation are needed to allow an adequate generalization of the benefits of chromium on human health.

Identifiants

pubmed: 34710707
pii: S0946-672X(21)00169-3
doi: 10.1016/j.jtemb.2021.126879
pii:
doi:

Substances chimiques

Thiobarbituric Acid Reactive Substances 0
Chromium 0R0008Q3JB
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

126879

Informations de copyright

Copyright © 2021 Elsevier GmbH. All rights reserved.

Auteurs

Mojgan Morvaridzadeh (M)

Songhor Healthcare Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

M Dulce Estêvão (MD)

Universidade do Algarve, Escola Superior de Saúde, Campus de Gambelas, Faro, Portugal.

Mostafa Qorbani (M)

Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hafez Heydari (H)

Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.

Ava Sadat Hosseini (AS)

Department of Education and Health Promotion, School of Health, Iran University of Medical Sciences, Tehran, Iran.

Siavash Fazelian (S)

Clinical Research Development Unit, Ayatollah Kashani Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Andrej Belančić (A)

Department of Clinical Pharmacology, Clinical Hospital Centre Rijeka, Rijeka, Croatia.

Emma Persad (E)

Department for Evidence-based Medicine and Evaluation, Danube University Krems, Krems, Austria.

Gholamreza Rezamand (G)

Colorectal Research Center, Iran University of Medical Sciences, Rasoul-e- Akram Hospital, Sattarkhan Ave, Niyayesh St., Tehran, Iran. Electronic address: Rezamandreza@yahoo.com.

Javad Heshmati (J)

Songhor Healthcare Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: javad.heshmati@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH